Re Shape Lifesciences Inc. - Understand $rsls stock

$RSLS Market Cap: $2.847 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$8.183M

TTM

Gross Margin

68.34%

TTM

Net Earnings

-$7.067M

TTM

Current Assets

$5.338M

Q3 2024

Current Liabilities

$4.025M

Q3 2024

Current Ratio

132.62%

Q3 2024

Total Assets

$5.615M

Q3 2024

Total Liabilities

$4.128M

Q3 2024

Book Value

$1.487M

Q3 2024

Cash

$743.0K

Q3 2024

P/E

-0.4029

Nov 13, 2024 EST

Free Cash Flow

-$5.892M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Revenue	$8.678M	$11.24M	$13.60M	$11.30M	$3.281M	$9.100M	$9.900M	$3.400M	$4.000M	$3.539M	$0.00	$310.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-22.79%	-17.35%	20.36%	244.38%	-63.95%	-8.08%	191.18%	-15.0%	13.03%		-100.0%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Revenue	$8.678M	$11.24M	$13.60M	$11.30M	$3.281M	$9.100M	$9.900M	$3.400M	$4.000M	$3.539M	$0.00	$310.0K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Cost Of Revenue	$3.130M	$4.438M	$5.252M	$5.037M	$2.950M	$5.423M	$4.829M	$2.809M	$2.503M	$2.912M	$0.00	$230.0K	$0.00
Gross Profit	$5.548M	$6.802M	$8.348M	$6.262M	$331.0K	$3.678M	$5.085M	$584.0K	$1.536M	$627.0K	$0.00	$80.00K	$0.00
Gross Profit Margin	63.93%	60.52%	61.38%	55.42%	10.09%	40.42%	51.36%	17.18%	38.4%	17.72%		25.81%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Selling, General & Admin	$7.548M	$14.09M	$9.165M	$4.694M	$16.67M	$29.95M	$28.83M	$10.22M	$3.491M	$4.700M	$13.66M	$11.96M	$8.580M	$7.680M	$8.630M	$8.600M	$6.970M	$3.760M	$2.320M
YoY Change	-46.44%	53.77%	95.25%	-71.84%	-44.34%	3.87%	182.17%	192.67%	-25.72%	-65.59%	14.21%	39.39%	11.72%	-11.01%	0.35%	23.39%	85.37%	62.07%	55.7%
% of Gross Profit	136.05%	207.19%	109.79%	74.96%	5035.65%	814.19%	566.94%	1749.49%	227.28%	749.6%		14950.0%
Research & Development	$2.315M	$2.537M	$2.522M	$3.498M	$6.893M	$10.70M	$10.65M	$9.872M	$12.98M	$5.767M	$11.08M	$10.67M	$16.67M	$8.500M	$15.58M	$27.67M	$21.05M	$14.36M	$8.830M
YoY Change	-8.75%	0.59%	-27.9%	-49.25%	-35.56%	0.47%	7.85%	-23.93%	125.04%	-47.95%	3.84%	-35.99%	96.12%	-45.44%	-43.69%	31.45%	46.59%	62.63%	401.7%
% of Gross Profit	41.73%	37.3%	30.21%	55.86%	2082.48%	290.84%	209.38%	1690.41%	844.92%	919.78%		13337.5%
Depreciation & Amortization	$121.0K	$330.0K	$232.0K	$15.00K	$479.0K	$581.0K	$330.0K	$192.0K	$189.5K	$188.9K	$170.0K	$230.0K	$300.0K	$380.0K	$420.0K	$510.0K	$400.0K	$180.0K	$60.00K
YoY Change	-63.33%	42.24%	1446.67%	-96.87%	-17.56%	76.06%	71.88%	1.32%	0.31%	11.12%	-26.09%	-23.33%	-21.05%	-9.52%	-17.65%	27.5%	122.22%	200.0%	500.0%
% of Gross Profit	2.18%	4.85%	2.78%	0.24%	144.71%	15.8%	6.49%	32.88%	12.34%	30.13%		287.5%
Operating Expenses	$20.93M	$53.15M	$64.85M	$18.72M	$23.56M	$40.64M	$39.48M	$20.09M	$16.47M	$10.47M	$24.73M	$22.63M	$25.26M	$16.18M	$24.21M	$36.27M	$28.03M	$18.12M	$11.15M
YoY Change	-60.62%	-18.04%	246.43%	-20.55%	-42.03%	2.96%	96.51%	21.98%	57.34%	-57.67%	9.28%	-10.41%	56.12%	-33.17%	-33.25%	29.4%	54.69%	62.51%	243.08%
Operating Profit	-$15.38M	-$46.35M	-$56.50M	-$12.46M	-$23.23M	-$36.97M	-$34.39M	-$19.51M	-$14.93M	-$9.840M	-$24.73M	-$22.55M	-$25.26M
YoY Change	-66.81%	-17.96%	353.57%	-46.38%	-37.16%	7.48%	76.32%	30.62%	51.76%	-60.21%	9.67%	-10.73%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Interest Expense	$26.00K	-$113.0K	-$832.0K	-$2.049M	-$385.0K	-$226.0K	-$135.0K	-$477.0K	-$549.0K	-$220.0K	-$930.0K	-$890.0K	-$710.0K	-$1.090M	-$7.670M	-$1.580M	-$450.0K	$430.0K	-$70.00K
YoY Change	-123.01%	-86.42%	-59.39%	432.21%	70.35%	67.41%	-71.7%	-13.11%	149.55%	-76.34%	4.49%	25.35%	-34.86%	-85.79%	385.44%	251.11%	-204.65%	-714.29%	-65.0%
% of Operating Profit
Other Income/Expense, Net	$122.0K	$11.00K	-$2.813M	-$411.0K	-$61.00K	-$189.0K	-$239.0K	-$19.00K	-$41.00K	$3.000K	-$120.0K	-$20.00K	-$30.00K	-$80.00K	-$50.00K	-$20.00K	-$100.0K	$0.00	$10.00K
YoY Change	1009.09%	-100.39%	584.43%	573.77%	-67.72%	-20.92%	1157.89%	-53.66%	-1466.67%	-102.5%	500.0%	-33.33%	-62.5%	60.0%	150.0%	-80.0%		-100.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Pretax Income	-$11.34M	-$46.59M	-$62.04M	-$21.81M	-$23.68M	-$37.38M	-$34.77M	-$20.47M	-$25.50M	-$26.13M	-$25.78M	-$23.46M	-$26.00M	-$17.35M	-$31.93M	-$37.88M	-$28.58M	-$17.69M	-$11.22M
YoY Change	-75.67%	-24.9%	184.44%	-7.88%	-36.66%	7.52%	69.86%	-19.73%	-2.41%	1.35%	9.89%	-9.77%	49.86%	-45.66%	-15.71%	32.54%	61.56%	57.66%	225.22%
Income Tax	$52.00K	-$380.0K	-$106.0K	-$181.0K	$14.00K	$11.00K	$10.00K	$2.000K	-$13.00K	$16.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$11.39M	-$46.21M	-$61.93M	-$21.63M	-$23.68M	-$37.38M	-$34.77M	-$20.47M	-$15.56M	-$9.890M	-$25.78M	-$23.46M	-$26.00M	-$17.35M	-$31.93M	-$37.88M	-$28.58M	-$17.69M	-$11.22M
YoY Change	-75.36%	-25.38%	186.33%	-8.64%	-36.66%	7.52%	69.86%	31.56%	57.3%	-61.64%	9.89%	-9.77%	49.86%	-45.66%	-15.71%	32.54%	61.56%	57.66%	225.22%
Net Earnings / Revenue	-131.22%	-411.16%	-455.39%	-191.43%	-721.61%	-410.77%	-351.16%	-601.97%	-388.93%	-279.46%		-7567.74%
Basic Earnings Per Share	-$1.91	-$108.90	-$5.67	-$5.55
Diluted Earnings Per Share	-$1.91	-$108.90	-$5.67	-$5.55	-$15.09M	-$58.91M	-$62.39M	-$36.61M	-$75370B	-$101900B	-$124100B	-$157100B	-$227900B	-$545500B	-$1699000B	-$3573000B	-$18560000B	-$1722000B	-$1092000B

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Cash & Short-Term Investments	$4.459M	$3.855M	$22.77M	$3.905M	$14.06M	$23.74M	$44.40M	$75.48M	$7.927M	$11.62M	$23.30M	$22.31M	$29.49M	$30.84M	$14.62M	$26.30M	$57.03M	$34.73M	$10.72M
YoY Change	15.67%	-83.07%	482.97%	-72.22%	-40.78%	-46.54%	-41.17%	852.1%	-31.77%	-50.13%	4.44%	-24.35%	-4.38%	110.94%	-44.41%	-53.88%	64.21%	223.97%
Cash & Equivalents	$4.459M	$3.855M	$22.77M	$3.905M	$14.06M	$21.19M	$21.11M	$72.98M	$7.927M	$11.62M	$23.30M	$22.31M	$28.49M	$30.84M	$14.62M	$21.06M	$48.73M	$17.54M	$10.72M
Short-Term Investments					$0.00	$2.548M	$23.29M	$2.500M	$9.180M	$12.34M		$0.00	$1.010M	$0.00	$0.00	$5.240M	$8.300M	$17.20M	$0.00
Other Short-Term Assets	$437.0K	$265.0K	$1.672M	$780.0K	$1.959M	$2.450M	$1.629M	$1.239M	$831.5K	$421.7K	$550.0K	$770.0K	$1.000M	$6.970M	$470.0K	$420.0K	$430.0K	$70.00K	$140.0K
YoY Change	64.91%	-84.15%	114.36%	-60.18%	-20.04%	50.4%	31.48%	49.01%	97.19%	-23.33%	-28.57%	-23.0%	-85.65%	1382.98%	11.9%	-2.33%	514.29%	-50.0%
Inventory	$3.741M	$3.611M	$3.003M	$0.00	$1.936M	$1.580M	$1.418M	$827.0K	$1.686M	$980.5K	$1.130M	$1.270M	$1.070M	$0.00
Prepaid Expenses
Receivables	$1.659M	$2.180M	$2.815M	$0.00	$285.0K	$870.0K	$4.223M	$515.0K	$57.93K	$2.810K	$20.00K	$50.00K
Other Receivables	$0.00	$0.00	$0.00	$3.150M	$0.00	$12.00K	$85.00K	$5.000K	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$10.30M	$9.911M	$30.26M	$7.835M	$18.24M	$28.65M	$51.76M	$78.06M	$10.50M	$13.02M	$24.99M	$24.40M	$31.57M	$37.80M	$15.10M	$26.79M	$57.55M	$34.96M	$10.88M
YoY Change	3.88%	-67.24%	286.15%	-57.03%	-36.35%	-44.65%	-33.7%	643.23%	-19.36%	-47.88%	2.42%	-22.71%	-16.48%	150.33%	-43.64%	-53.45%	64.62%	221.32%
Property, Plant & Equipment	$310.0K	$869.0K	$1.720M	$1.478M	$2.158M	$1.739M	$1.346M	$717.0K	$326.3K	$481.5K	$580.0K	$610.0K	$630.0K	$740.0K	$970.0K	$1.260M	$1.490M	$1.100M	$640.0K
YoY Change	-64.33%	-49.48%	16.37%	-31.51%	24.09%	29.2%	87.73%	119.74%	-32.24%	-16.98%	-4.92%	-3.17%	-14.86%	-23.71%	-23.02%	-15.44%	35.45%	71.88%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$57.00K	$102.0K	$1.456M	$1.304M					$757.8K	$879.9K	$820.0K	$1.080M	$290.0K	$140.0K	$150.0K	$220.0K	$10.00K	$10.00K	$40.00K
YoY Change	-44.12%	-92.99%	11.66%						-13.88%	7.31%	-24.07%	272.41%	107.14%	-6.67%	-31.82%	2100.0%	0.0%	-75.0%
Total Long-Term Assets	$367.0K	$1.231M	$24.00M	$2.782M	$2.158M	$1.739M	$1.346M	$717.0K	$1.084M	$1.361M	$1.400M	$1.700M	$920.0K	$890.0K	$1.110M	$1.490M	$1.500M	$1.100M	$680.0K
YoY Change	-70.19%	-94.87%	762.8%	28.92%	24.09%	29.2%	87.73%	-33.86%	-20.37%	-2.76%	-17.65%	84.78%	3.37%	-19.82%	-25.5%	-0.67%	36.36%	61.76%
Total Assets	$10.66M	$11.14M	$54.26M	$10.62M	$20.39M	$30.39M	$53.10M	$78.78M	$11.59M	$14.39M	$26.39M	$26.10M	$32.49M	$38.69M	$16.21M	$28.28M	$59.05M	$36.06M	$11.56M
YoY Change
Accounts Payable	$1.689M	$1.926M	$3.468M	$615.0K	$648.0K	$1.159M	$1.276M	$595.0K	$172.1K	$399.3K	$130.0K	$340.0K	$430.0K	$130.0K	$30.00K	$160.0K	$300.0K	$680.0K	$320.0K
YoY Change	-12.31%	-44.46%	463.9%	-5.09%	-44.09%	-9.17%	114.45%	245.83%	-56.92%	207.18%	-61.76%	-20.93%	230.77%	333.33%	-81.25%	-46.67%	-55.88%	112.5%
Accrued Expenses	$1.167M	$4.091M	$2.407M	$4.431M	$2.881M	$5.790M	$6.267M	$3.997M	$3.597M	$4.346M	$4.710M	$4.200M	$6.820M	$2.950M	$2.370M	$3.040M	$2.370M	$1.700M	$930.0K
YoY Change	-71.47%	69.96%	-45.68%	53.8%	-50.24%	-7.61%	56.79%	11.13%	-17.24%	-7.73%	12.14%	-38.42%	131.19%	24.47%	-22.04%	28.27%	39.41%	82.8%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due			$0.00		$24.00K	$9.930M	$1.958M	$0.00	$717.4K	$4.000M	$4.000M	$3.000M	$2.310M	$920.0K	$3.880M	$2.680M	$5.080M	$2.650M	$1.000M
YoY Change					-99.76%	407.15%		-100.0%	-82.07%	0.0%	33.33%	29.87%	151.09%	-76.29%	44.78%	-47.24%	91.7%	165.0%
Total Short-Term Liabilities	$3.777M	$7.481M	$7.331M	$5.046M	$3.977M	$17.23M	$10.01M	$4.592M	$4.486M	$7.721M	$8.840M	$7.540M	$9.560M	$4.000M	$6.280M	$5.880M	$7.750M	$5.030M	$2.240M
YoY Change	-49.51%	2.05%	45.28%	26.88%	-76.92%	72.12%	118.01%	2.36%	-41.9%	-12.66%	17.24%	-21.13%	139.0%	-36.31%	6.8%	-24.13%	54.08%	124.55%
Long-Term Debt	$0.00	$0.00	$0.00	$430.0K	$0.00	$0.00	$7.964M	$9.881M	$549.8K	$0.00	$2.870M	$6.680M	$2.880M	$4.980M	$3.880M	$11.00M	$6.020M	$1.730M	$7.340M
YoY Change			-100.0%			-100.0%	-19.4%	1697.23%		-100.0%	-57.04%	131.94%	-42.17%	28.35%	-64.73%	82.72%	247.98%	-76.43%
Other Long-Term Liabilities	$223.0K	$0.00	$300.0K	$476.0K	$567.0K	$48.00K	$13.00K		$2.878M	$0.00				$0.00	$470.0K		$0.00	$730.0K	$0.00
YoY Change		-100.0%	-36.97%	-16.05%	1081.25%	269.23%								-100.0%			-100.0%
Total Long-Term Liabilities	$223.0K	$0.00	$300.0K	$906.0K	$567.0K	$48.00K	$7.977M	$9.881M	$3.428M	$0.00	$2.870M	$6.680M	$2.880M	$4.980M	$4.350M	$11.00M	$6.020M	$2.460M	$7.340M
YoY Change		-100.0%	-66.89%	59.79%	1081.25%	-99.4%	-19.27%	188.28%		-100.0%	-57.04%	131.94%	-42.17%	14.48%	-60.45%	82.72%	144.72%	-66.49%
Total Liabilities	$4.000M	$7.481M	$8.186M	$5.952M	$4.544M	$17.28M	$17.99M	$14.47M	$7.914M	$7.721M	$11.71M	$14.22M	$12.44M	$8.980M	$10.63M	$16.87M	$13.77M	$7.490M	$9.590M
YoY Change	-46.53%	-8.61%	37.53%	30.99%	-73.7%	-3.94%	24.29%	82.89%	2.49%	-34.06%	-17.65%	14.31%	38.53%	-15.52%	-36.99%	22.51%	83.85%	-21.9%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020
Basic Shares Outstanding	5.957M	424.4K	10.93M	3.898M
Diluted Shares Outstanding	5.957M	424.4K	10.93M	3.898M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $2.8475 Million

About ReShape Lifesciences Inc.

ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 31 full-time employees. The company went IPO on 2016-10-06. The firm offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Industry: Pharmaceutical Preparations Peers: Abbott Laboratories ALLIED HEALTHCARE PRODUCTS INC MICRON SOLUTIONS INC /DE/ Avinger Inc Cell MedX Corp Motus GI Holdings Inc Intelligent Bio Solutions Inc LogicMark Inc VIVEVE MEDICAL, INC.